In clinical studies, participants typically used semaglutide for at least 68 weeks (about 16 months) to achieve significant and sustained weight loss
Recent data indicate new, multifactorial roles for acylcarnitines in neuroprotection
Weight loss itself can have complex psychological effects
DPP-4 inhibitors reduce HbA 1c levels and have a low risk of hypoglycaemia or other adverse events [38], except for a potential risk of hospitalisation for heart failure in the case of saxagliptin [38]
PlexusDx's Precision Peptide Genetic Test identifies key variants in the GLP1R, GIPR, FTO, and MC4R genes that influence your metabolic response to GLP-1 therapy
The most common side effect involves gastrointestinal symptoms, particularly nausea and constipation during initial GLP-1 dose escalation, though metformin's typical diarrhea effect sometimes partially offsets this